Analyst Josh Jennings from TD Cowen maintained a Hold rating on Edwards Lifesciences (EW – Research Report) and keeping the price target at ...

Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

Edwards Lifesciences (EW) announced one-year data highlighting the continued performance of its SAPIEN 3 Ultra RESILIA valve. The data were ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, provides products and technologies for structural ...

On Friday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $70.48 which represents a slight increase of $0.10 or 0.14% from the prior close of $70.38. The stock opened at ...

Edwards Lifesciences Co. (NYSE:EW – Free Report) – Zacks Research dropped their Q1 2025 EPS estimates for shares of Edwards ...

On Thursday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $70.38 which represents a slight increase of $0.84 or 1.21% from the prior close of $69.54. The stock opened at ...

NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE ...

Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic ...

LOS ANGELES, CA / ACCESSWIRE / November 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences ...